GENE ONLINE|News &
Markets & Deals
Biotech IPO Market Thaws: Eikon, Agomab, SpyGlass and Veradermics Lead Billion-Dollar Revival
2026-02-09
[Illustrations] 2026 Obesity’s Second Wave: Market Fragmentation Starts to Challenge First-Generation Dominance
2026-02-05
[Illustrations] 2026 Biopharma’s “Clearing Year”: IRA, BIOSECURE, and the Phase 3 Threshold Becoming the True Litmus Test
2026-02-05
Moderna and Recordati Form Strategic Alliance to Commercialize mRNA Therapy for Propionic Acidemia
2026-02-04
AstraZeneca Pledges $15 Billion China Investment and Signs Up to $18.5 Billion CSPC Obesity Deal
2026-02-02
Why System Integration Is Eclipsing the Chip War: AI’s Energy, Infrastructure, and Sovereignty Bottleneck
2026-01-28
Facing a Patent Cliff, GSK Bets on a Potential Best-in-Class Food Allergy Biologic in $2.2B RAPT Deal
2026-01-20
AbbVie Bets $5.6 Billion on PD-1×VEGF Bispecifics, Licensing RemeGen’s RC148 to Expand Its Oncology Arsenal
2026-01-13
Japan’s Eisai and U.S.-Based Nuvation Bio Secure Europe, Middle East Rights for Lung Cancer Drug in €195M Deal
2026-01-13
From Pipeline to Payday: The Rare Disease Assets Most Likely to Spark a 2026 M&A Land-Grab
2026-01-13
First-of-Its-Kind AI Drug Discovery Lab: NVIDIA, Eli Lilly Announce $1B Investment at J.P. Morgan Healthcare
2026-01-12
Rakuten Medical Closes $100 Million Series F to Push Lead Cancer Therapy Toward FDA Review
2026-01-09
Early 2026 Biotech Fundraising: Parabilis and EpiBiologics Secure Major Rounds to Advance Oncology Pipelines
2026-01-09
DISCO Pharmaceuticals and Amgen Ink Exclusive License Deal to Advance Surfaceome-Targeted Cancer Therapies
2026-01-07
LATEST
Trip.com Group Limited to Release Q4 and Full-Year 2025 Financial Results on February 25, 2026
2026-02-09
FireFox Gold Reports 54.91 g/t Gold Over 1.95 Meters in Northeast Zone Expansion at Mustajärvi Project
2026-02-09
